(12) United States Patent (10) Patent No.: US 9,655,935 B2 Dreher Et Al

Total Page:16

File Type:pdf, Size:1020Kb

(12) United States Patent (10) Patent No.: US 9,655,935 B2 Dreher Et Al USOO9655935B2 (12) United States Patent (10) Patent No.: US 9,655,935 B2 Dreher et al. (45) Date of Patent: *May 23, 2017 (54) POMEGRANATE FRUIT POLYPHENOL continuation-in-part of application No. 1 1/687,480, COMPOSITION AND METHODS OF USE filed on Mar. 16, 2007, now Pat. No. 7,943,185. AND MANUFACTURE THEREOF (60) Provisional application No. 60/888,763, filed on Feb. 7, 2007, provisional application No. 60/888,762, filed (71) Applicant: POM Wonderful LLC, Los Angeles, on Feb. 7, 2007. CA (US) (51) Int. Cl. (72) Inventors: Mark Dreher, Wimberley, TX (US); A636/85 (2006.01) Harley Liker, Los Angeles, CA (US); A63L/7048 (2006.01) Yair Steve Henig, Beverly Hills, CA A63L/366 (2006.01) (US) (52) U.S. Cl. CPC .......... A61K 36/185 (2013.01); A61 K3I/366 (73) Assignee: POM WONDERFUL, LLC, Los (2013.01); A61 K3I/7048 (2013.01) Angeles, CA (US) (58) Field of Classification Search None (*) Notice: Subject to any disclaimer, the term of this See application file for complete search history. patent is extended or adjusted under 35 U.S.C. 154(b) by 48 days. (56) References Cited This patent is Subject to a terminal dis U.S. PATENT DOCUMENTS claimer. 9,056,083 B2 * 6/2015 Dreher ................. A61K 36,185 (21) Appl. No.: 14/724,761 * cited by examiner (22) Filed: May 28, 2015 Primary Examiner — Chris R Tate (65) Prior Publication Data Assistant Examiner — Randall Winston (74) Attorney, Agent, or Firm — Cotman IP Law Group, US 2016/002275O A1 Jan. 28, 2016 PLC Related U.S. Application Data (57) ABSTRACT (63) Continuation of application No. 13/299.356, filed on A pharmaceutical composition with an active pharmaceuti Nov. 17, 2011, now Pat. No. 9,056,083, which is a cal ingredient including a pomegranate fruit polyphenol continuation-in-part of application No. 12/564,878, extract. The pomegranate fruit polyphenol extract includes filed on Sep. 22, 2009, now Pat. No. 8,658.220, which at least about 3% combined punicalagin A and punicalagin is a continuation of application No. 11/137,248, filed B by weight, less than about 5% elagic acid and their on May 24, 2005, now Pat. No. 7,611,738, said derivatives by weight, and less than about 1% anthocyanins application No. 13/299.356 is a continuation-in-part by weight. of application No. 1 1/745,440, filed on May 7, 2007, now Pat. No. 8,758,832, which is a 13 Claims, No Drawings US 9,655,935 B2 1. 2 POMEGRANATE FRUIT POLYPHENOL For example, a major polyphenol antioxidant called puni COMPOSITION AND METHODS OF USE calagin can by hydrolyzed into ellagic acid. Once puni AND MANUFACTURE THEREOF calagin hydrolyzes into ellagic acid its ability to offer antioxidant potency to the body is reduced since free elagic CROSS REFERENCE TO RELATED acid is not as bioavailable. When punicalagins are preserved APPLICATIONS in their original unhydrolyzed and then consumed, they can be absorbed into the bloodstream, and greater health benefits The present application is a continuation of U.S. patent can be obtained. Punicalagins are 100% water-soluble, application Ser. No. 13/299,356, filed on Nov. 17, 2011, highly bioavailable, and shown to possess a high absorption which is a continuation-in-part of U.S. patent application 10 rate up to 95%. Not only do punicalagins offer antioxidant activity on their own, they can break up into Smaller Ser. No. 12/564,878, filed on Sep. 22, 2009, which is a polyphenols that are also absorbed into the body. Punicala continuation application of U.S. patent application Ser. No. gins are one important component of pomegranate polyphe 11/137,248, filed on May 24, 2005, now issued as U.S. Pat. nols, but the total composition of the polyphenols them No. 7,611,738, all of which are herein incorporated by 15 selves is a complex mixture of numerous other components. reference for completeness of disclosure; the present appli Predominant types of pomegranate polyphenolic com cation is also a continuation-in-part of U.S. patent applica pounds are hydrolyzable tannins, which are found in the tion Ser. No. 1 1/745,440, filed on May 7, 2007, which claims peels (rind, husk, or pericarp), membranes, and piths of the priority to U.S. Provisional Application Ser. No. 60/888,763, fruit. Hydrolyzable tannins, including punicalagin, are Sus and U.S. Provisional Application Ser. No. 60/888,762, both ceptible to enzymatic and non-enzymatic hydrolysis. Other filed Feb. 7, 2007, and which is a continuation-in-part of hydrolyzable tannins are include gallic acid and elagic acid U.S. patent application Ser. No. 1 1/687,480, now issued as esters of core molecules that consist of polyols, such as U.S. Pat. No. 7,943,185, all of which are herein incorporated Sugars. During hydrolysis, gallotannins yield gallic acid and by reference for completeness of disclosure. glucose while elagitannins yield ellagic acid and glucose. 25 The reported soluble polyphenol content in pomegranate BACKGROUND OF THE INVENTION juice varies within the limits of approximately 0.2% to approximately 1.5%, and ellagic acid was measured in Field of the Invention commercial juices around 100 to around 3000 mg/L. The disclosure provided herein relates generally to pome For the reasons above, many of products claiming to granate extracts. More particularly, but not by way of 30 contain “natural pomegranate' may in fact have less con limitation, one or more embodiments enable oral or enteral centrated key ingredients or phytochemicals that have spe dosage forms containing phytochemicals from pomegranate cific health benefits. Hence there is a need to find ways to in a quantity reflecting that of the natural fruit itself. concentrate pomegranate phytochemicals, including poly Description of the Related Art phenol antioxidants such as punicalagins and its automers, The pomegranate is acclaimed for its health benefits and 35 in their bioavailable and bioactive. for its disease-fighting antioxidant potential. Antioxidants For the reasons above, many of products claiming to are important because they are believed to protect the body contain “natural pomegranate may in fact lack key ingre against free radicals, the harmful molecules that can cause dients or phytochemicals that have specific health benefits. heart disease, premature aging, Alzheimer's disease, blind Hence there is a need to find ways to concentrate pome ness, and a variety of cancers. 40 granate phytochemicals, including polyphenol antioxidants There are many kinds of antioxidants, some produced by Such as punicalagins and its automers, in their bioavailable the body and others derived from the foods we eat. When the and bioactive forms. body's natural antioxidant defenses are lowered, or greater For at least the reasons described above there is a need for amounts of free radicals are produced, the body becomes processes for producing an oral or enteral dosage form more dependent upon food sources of antioxidants. The 45 containing key phytochemicals from pomegranates. consumption of phytochemical-rich diet is associated with a reduced risk of chronic human illnesses such as certain types SUMMARY OF THE INVENTION of cancers, inflammation, and cardiovascular and neurode generative diseases. One or more embodiments of the pomegranate fruit Studies show pomegranate juice has more polyphenol 50 polyphenol extract described herein are directed to a phar antioxidants than any other drink, Such as red wine, green maceutical composition including an active pharmaceutical tea, blueberry juice, cranberry juice and orange juice. Two ingredient. The active pharmaceutical ingredient includes a common ways of consuming pomegranates are by eating the pomegranate fruit polyphenol extract including at least fleshy arils of the pomegranate fruit itself and by drinking about 3% combined punicalagin A and punicalagin B by the juice obtained from the arils. 55 weight, and less than about 5% elagic acid and their There are studies illustrating the beneficial effects of derivatives by weight, and less than about 1% anthocyanins pomegranate phytochemicals, including polyphenols, by weight. proanthocyanidins, hydrolysable tannins, etc. Hence it is The pharmaceutical composition further includes a phar desirable to gain whatever beneficial effects might be pres maceutically acceptable carrier in instances where a carrier ent by consuming pomegranate and its phytochemicals. The 60 is desired. oral route is the least invasive, most convenient route for In one or more embodiments of the pharmaceutical com administering pomegranate phytochemicals on a routine position, the pomegranate fruit polyphenol extract may basis. However, the pomegranate fruit is a difficult fruit to include between about 3% to about 8% combined puni consume and certain pomegranate phytochemicals may lose calagin A and punicalagin B by weight. For example, the their health beneficial effects by undergoing chemical reac 65 pomegranate fruit polyphenol extract may include between tions into less bioavailable and/or less bioactive forms about 3% to about 4% combined punicalagin A and puni during processing and storage of juices and extracts. calagin B by weight. In another instance, the pomegranate US 9,655,935 B2 3 4 fruit polyphenol extract may contain between about 4.5% to As used herein, the term “phytochemicals' refers collec about 8% combined punicalagin A and punicalagin B by tively to compounds which are naturally-occurring in the weight. In one or more embodiments, the pomegranate fruit pomegranate and to reaction products and metabolites of polyphenol extract includes at least about 20% combined these compounds, which are considered to have a beneficial punicalagin A and punicalagin B by weight. 5 effect on the human or animal health. Examples of such In one or more embodiments of the pharmaceutical com phytochemicals include, but not limited to phenolics, poly position, the pomegranate fruit polyphenol extract includes phenols, and phenolic acids, sterols and triterpenoids, fatty at least about 15% combined punicalagin and punicalin by acids and triglycerides, and alkaloids.
Recommended publications
  • A Review on Antihyperglycemic and Antihepatoprotective Activity of Eco-Friendly Punica Granatum Peel Waste
    Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2013, Article ID 656172, 10 pages http://dx.doi.org/10.1155/2013/656172 Review Article A Review on Antihyperglycemic and Antihepatoprotective Activity of Eco-Friendly Punica granatum Peel Waste Sushil Kumar Middha,1 Talambedu Usha,2 and Veena Pande1 1 Department of Biotechnology, Bhimtal Campus, Kumaun University, Nainital, Uttarakhand 263136, India 2 Department of Biotechnology & Biochemistry, Maharani Lakshmi Ammanni College for Women, Bangalore 560012, India Correspondence should be addressed to Veena Pande; veena [email protected] Received 28 December 2012; Revised 25 March 2013; Accepted 25 April 2013 Academic Editor: Edwin L. Cooper Copyright © 2013 Sushil Kumar Middha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Over the past decade, pomegranate (Punica granatum) is entitled as a wonder fruit because of its voluminous pharmacological properties. In 1830, P. g ranatum fruit was first recognized in United States Pharmacopeia; the Philadelphia edition introduced the rind of the fruit, the New York edition the bark of the root and further 1890 edition the stem bark was introduced. There are significant efforts and progress made in establishing thepharmacological mechanisms of peel (pericarp or rind) and the individual constituents responsible for them. This review provides an insight on the phytochemical components that contribute too antihyperglycemic, hepatoprotective, antihyperlipidemic effect, and numerous other effects of wonderful, economic, and eco- friendly pomegranate peel extract (PP). 1. Introduction containing sacs packed with a fleshy, juicy, red or whitish pulp.
    [Show full text]
  • Evaluation of Punicalagin Niosomes for Skin Aging
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 24 March 2021 Evaluation of Punicalagin Niosomes for Skin Aging Ebtesam A. Mohamada, Aya A. Alyb, Aya A. Khalafb, Mona I. Ahmedb, Reham M. Kamelb, Sherouk M. Abdelnabyb, Yasmine H. Abdelzaherb, Marize G. Sedrak b, Shaker A. Mousac a Biophysics Department, Faculty of Science, Cairo University, Cairo, Egypt; b Biotechnology / Biomolecular Chemistry Program, Faculty of Science, Cairo University, Cairo, Egypt; c The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA *Corresponding Author: Shaker A. Mousa, PhD, MBA, FACC, FACB Professor of Pharmacology and Chairman of The Pharmaceutical Research Institute Albany College of Pharmacy and Health Sciences Rensselaer, NY 12144, USA Email: [email protected] Tel: +1-518-694-7397 & Fax: +1-518-694-7567 Abstract Skin aging is one of the most common problems facing humanity. It occurs because of altering the balance between free radicals and antioxidants and increasing the amount of the reactive oxygen species (ROS) in skin cells, which leads to oxidative stress especially when exposed to UV radiation. Antioxidants can neutralize the harmful effects of ROS, and secondary plant metabolites can help protect against UV radiation. In this study, punicalagin was extracted from pomegranate and concentrations of total polyphenolics and flavonoids were determined and antioxidant activities measured. Punicalagin was loaded onto niosomes and its morphology and release were studied. An in vitro study was performed on human fibroblast cell line HFB4 cells with aging induced by H2O2 and UV radiation. Cell cycle arrest was studied and different genes (MMP3, Col1A1, Timp3, and TERT) involved in the skin aging process were selected to measure punicalagin's effect.
    [Show full text]
  • Pomegranate: Nutraceutical with Promising Benefits on Human Health
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 8 September 2020 Review Pomegranate: nutraceutical with promising benefits on human health Anna Caruso 1, +, Alexia Barbarossa 2,+, Antonio Tassone 1 , Jessica Ceramella 1, Alessia Carocci 2,*, Alessia Catalano 2,* Giovanna Basile 1, Alessia Fazio 1, Domenico Iacopetta 1, Carlo Franchini 2 and Maria Stefania Sinicropi 1 1 Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende (Italy); anna.caruso@unical .it (Ann.C.), [email protected] (A.T.), [email protected] (J.C.), [email protected] (G.B.), [email protected] (A.F.), [email protected] (D.I.), [email protected] (M.S.S.) 2 Department of Pharmacy‐Drug Sciences, University of Bari “Aldo Moro”, 70126, Bari (Italy); [email protected] (A.B.), [email protected] (Al.C.), [email protected] (A.C.), [email protected] (C.F.) + These authors equally contributed to this work. * Correspondence: [email protected] Abstract: The pomegranate, an ancient plant native to Central Asia, cultivated in different geographical areas including the Mediterranean basin and California, consists of flowers, roots, fruits and leaves. Presently, it is utilized not only for the exterior appearance of its fruit but above all, for the nutritional and health characteristics of the various parts composing this last one (carpellary membranes, arils, seeds and bark). The fruit, the pomegranate, is rich in numerous chemical compounds (flavonoids, ellagitannins, proanthocyanidins, mineral salts, vitamins, lipids, organic acids) of high biological and nutraceutical value that make it the object of study for many research groups, particularly in the pharmaceutical sector.
    [Show full text]
  • Punicalagin Content and Antifungal Activity of Different
    horticulturae Article Punicalagin Content and Antifungal Activity of Different Pomegranate (Punica ganatum L.) Genotypes Domenico Rongai 1,*, Patrizio Pulcini 1, Giovanni Di Lernia 1, Paolo Nota 1, Pjerin Preka 2 and Filomena Milano 1 1 CREA-DC Research Centre for Plant Protection and Certification, via C.G Bertero, 22, 00156 Rome, Italy 2 CREA-OFA Research Centre for Olive, Citrus and Tree fruit, Via di Fioranello, 52, 00134 Rome, Italy * Correspondence: [email protected] Received: 16 May 2019; Accepted: 1 July 2019; Published: 16 July 2019 Abstract: This study investigated the antifungal activity of a number of pomegranate genotypes. Since the main compound of pomegranate extract is punicalagin, an important substance involved in antifungal and antimicrobial activity, we analyzed the contents of punicalagin (α and β) in 21 different pomegranate genotypes. Ellagic acid content, total phenolic content, acidity and pH were also determined. This work allowed us to determine which genotypes of pomegranate can be used to obtain extracts with the highest content of punicalagin, with the goal of developing a green alternative to synthetic pesticides. To improve the extraction system from pomegranate peel fruits, several different solvents were tested. All the pomegranate genotypes tested showed antifungal activity; some genotypes were able to almost completely inhibit the fungus, while others had very low inhibitory activity. Research results also showed that the use of water as a solvent for extraction is very effective, especially when it is combined with ethanol. This is very important for the practical use of the extracts since water is economical and environmentally friendly. The research showed that among the genotypes there is also great variability regarding the chemical parameters.
    [Show full text]
  • Production and Extraction by Solid-State Fermentation. a Review
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Universidade do Minho: RepositoriUM Biotechnology Advances 29 (2011) 365–373 Contents lists available at ScienceDirect Biotechnology Advances journal homepage: www.elsevier.com/locate/biotechadv Research review paper Bioactive phenolic compounds: Production and extraction by solid-state fermentation. A review Silvia Martins a, Solange I. Mussatto a,⁎, Guillermo Martínez-Avila b, Julio Montañez-Saenz c, Cristóbal N. Aguilar b, Jose A. Teixeira a a Institute for Biotechnology and Bioengineering (IBB), Centre of Biological Engineering, University of Minho, Campus Gualtar, 4710–057, Braga, Portugal b Food Research Department, School of Chemistry, Autonomous University of Coahuila, Blvd. Venustiano Carranza S/N Col. República Oriente, 25280, Saltillo, Coahuila, Mexico c Department of Chemical Engineering, School of Chemistry, Autonomous University of Coahuila, Blvd. Venustiano Carranza S/N Col. República Oriente, 25280, Saltillo, Coahuila, Mexico article info abstract Article history: Interest in the development of bioprocesses for the production or extraction of bioactive compounds from Received 27 July 2010 natural sources has increased in recent years due to the potential applications of these compounds in food, Received in revised form 20 January 2011 chemical, and pharmaceutical industries. In this context, solid-state fermentation (SSF) has received great Accepted 21 January 2011 attention because this bioprocess has potential to successfully convert inexpensive agro-industrial residues, Available online 1 February 2011 as well as plants, in a great variety of valuable compounds, including bioactive phenolic compounds. The aim Keywords: of this review, after presenting general aspects about bioactive compounds and SSF systems, is to focus on the Solid-state fermentation production and extraction of bioactive phenolic compounds from natural sources by SSF.
    [Show full text]
  • Oksana Et Al
    Journal of Medicinal Plants Research Vol. 6(13), pp. 2526-2539, 9 April, 2012 Available online at http://www.academicjournals.org/JMPR DOI: 10.5897/JMPR11.1695 ISSN 1996-0875 ©2012 Academic Journals Review Plant phenolic compounds for food, pharmaceutical and cosmeti сs production Sytar Oksana 1,2 , Brestic Marian 1,4 , Rai Mahendra 3 and Shao Hong Bo 1,4,5 * 1Department of Plant Physiology, Slovak University of Agriculture in Nitra, Tr. A. Hlinku 2, 949 76 Nitra, Slovakia. 2Department of Plant Physiology and Ecology, Taras Shevchenko National University of Kyiv, Volodymyrs'ka St. 64, 01601 Kyiv, Ukraine. 3Department of Biotechnology, SGB Amravati University, Maharashrta, India. 4Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Chunhui Rd.17, Yantai 264003, China. 5Institute of Life Sciences Qingdao University of Science and Technology, Zhengzhou Road 53, Qingdao 266042, China. Accepted 17 February, 2012 The biochemical features and biological function of dietary phenols, which are widespread in the plant kingdom, have been described in the present review. The ways of phenols classification, which were collected from literature based on structural and biochemical characteristics with description of source and possible effects on human, organisms and environment have been presented. The bioactivities of phenolic compounds described in literature are reviewed to illustrate their potential for the development of pharmaceutical and agricultural products. Key words: Plant phenols, phenolic acids, flavonoids, cathecins, tannins, food industry. INTRODUCTION Phenolic compounds are plant secondary metabolites skeleton: C6 (simple phenol, benzoquinones), C6-C1 that constitute one of the most common and widespread (phenolic acid), C6-C2 (acetophenone, phenylacetic groups of substances in plants (Whiting, 2001).
    [Show full text]
  • Ellagitannins in Cancer Chemoprevention and Therapy
    toxins Review Ellagitannins in Cancer Chemoprevention and Therapy Tariq Ismail 1, Cinzia Calcabrini 2,3, Anna Rita Diaz 2, Carmela Fimognari 3, Eleonora Turrini 3, Elena Catanzaro 3, Saeed Akhtar 1 and Piero Sestili 2,* 1 Institute of Food Science & Nutrition, Faculty of Agricultural Sciences and Technology, Bahauddin Zakariya University, Bosan Road, Multan 60800, Punjab, Pakistan; [email protected] (T.I.); [email protected] (S.A.) 2 Department of Biomolecular Sciences, University of Urbino Carlo Bo, Via I Maggetti 26, 61029 Urbino (PU), Italy; [email protected] 3 Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Corso d'Augusto 237, 47921 Rimini (RN), Italy; [email protected] (C.C.); carmela.fi[email protected] (C.F.); [email protected] (E.T.); [email protected] (E.C.) * Correspondence: [email protected]; Tel.: +39-(0)-722-303-414 Academic Editor: Jia-You Fang Received: 31 March 2016; Accepted: 9 May 2016; Published: 13 May 2016 Abstract: It is universally accepted that diets rich in fruit and vegetables lead to reduction in the risk of common forms of cancer and are useful in cancer prevention. Indeed edible vegetables and fruits contain a wide variety of phytochemicals with proven antioxidant, anti-carcinogenic, and chemopreventive activity; moreover, some of these phytochemicals also display direct antiproliferative activity towards tumor cells, with the additional advantage of high tolerability and low toxicity. The most important dietary phytochemicals are isothiocyanates, ellagitannins (ET), polyphenols, indoles, flavonoids, retinoids, tocopherols. Among this very wide panel of compounds, ET represent an important class of phytochemicals which are being increasingly investigated for their chemopreventive and anticancer activities.
    [Show full text]
  • The Activity of Pomegranate Extract Standardized 40% Ellagic Acid During the Healing Process of Incision Wounds in Albino Rats (Rattus Norvegicus)
    Veterinary World, EISSN: 2231-0916 RESEARCH ARTICLE Available at www.veterinaryworld.org/Vol.11/March-2018/11.pdf Open Access The activity of pomegranate extract standardized 40% ellagic acid during the healing process of incision wounds in albino rats (Rattus norvegicus) Wiwik Misaco Yuniarti, Hardany Primarizky and Bambang Sektiari Lukiswanto Department of Veterinary Clinical Science, Faculty of Veterinary Medicine, Universitas Airlangga, Mulyorejo, Campus C Unair, Surabaya, 60115, Indonesia. Corresponding author: Hardany Primarizky, e-mail: [email protected] Co-authors: WMY: [email protected], BSL: [email protected] Received: 17-11-2017, Accepted: 06-02-2018, Published online: 17-03-2018 doi: 10.14202/vetworld.2018.321-326 How to cite this article: Yuniarti WM, Primarizky H, Lukiswanto BS (2018) The activity of pomegranate extract standardized 40% ellagic acid during the healing process of incision wounds in albino rats (Rattus norvegicus), Veterinary World, 11(3): 321-326. Abstract Aim: This research aimed to evaluate the effects of pomegranate extract standardized to 40% ellagic acid on the incised wound in albino rats. Materials and Methods: Fifty albino rats were divided into 10 treatment groups. The five groups were sacrificed on the 8th day, while the others were sacrificed on the 15th day. Two groups of albino rats with incised wound were not treated at all (P0), the other two groups of albino rats with incised wound were treated with Betadine® (P1) ointment, and the rest of the groups were treated with pomegranate extract standardized to 40% ellagic acid with a concentration of 2.5% (P2), 5% (P3), and 7.5% (P4).
    [Show full text]
  • Pomegranate (Punica Granatum)
    Functional Foods in Health and Disease 2016; 6(12):769-787 Page 769 of 787 Research Article Open Access Pomegranate (Punica granatum): a natural source for the development of therapeutic compositions of food supplements with anticancer activities based on electron acceptor molecular characteristics Veljko Veljkovic1,2, Sanja Glisic2, Vladimir Perovic2, Nevena Veljkovic2, Garth L Nicolson3 1Biomed Protection, Galveston, TX, USA; 2Center for Multidisciplinary Research, University of Belgrade, Institute of Nuclear Sciences VINCA, P.O. Box 522, 11001 Belgrade, Serbia; 3Department of Molecular Pathology, The Institute for Molecular Medicine, Huntington Beach, CA 92647 USA Corresponding author: Garth L Nicolson, PhD, MD (H), Department of Molecular Pathology, The Institute for Molecular Medicine, Huntington Beach, CA 92647 USA Submission Date: October 3, 2016, Accepted Date: December 18, 2016, Publication Date: December 30, 2016 Citation: Veljkovic V.V., Glisic S., Perovic V., Veljkovic N., Nicolson G.L.. Pomegranate (Punica granatum): a natural source for the development of therapeutic compositions of food supplements with anticancer activities based on electron acceptor molecular characteristics. Functional Foods in Health and Disease 2016; 6(12):769-787 ABSTRACT Background: Numerous in vitro and in vivo studies, in addition to clinical data, demonstrate that pomegranate juice can prevent or slow-down the progression of some types of cancers. Despite the well-documented effect of pomegranate ingredients on neoplastic changes, the molecular mechanism(s) underlying this phenomenon remains elusive. Methods: For the study of pomegranate ingredients the electron-ion interaction potential (EIIP) and the average quasi valence number (AQVN) were used. These molecular descriptors can be used to describe the long-range intermolecular interactions in biological systems and can identify substances with strong electron-acceptor properties.
    [Show full text]
  • 10.21162/Pakjas/18.5663
    Pak. J. Agri. Sci., Vol. 55(1), 197-201;2018 ISSN (Print) 0552-9034, ISSN (Online) 2076-0906 DOI: 10.21162/PAKJAS/18.5663 http://www.pakjas.com.pk IN VITRO ANTIOXIDANT ACTIVITY AND PUNICALAGIN CONTENT QUANTIFICATION OF POMEGRANATE PEEL OBTAINED AS AGRO-WASTE AFTER JUICE EXTRACTION Anees Ahmed Khalil1,*, Moazzam Rafiq Khan2, Muhammad Asim Shabbir2 and Khalil-ur-Rahman3 1University Institute of Diet and Nutritional Sciences, Faculty of Allied Health Sciences, The University of Lahore- Lahore; 2National Institute of Food Science and Technology, Faculty of Food, Nutrition and Home Sciences, University of Agriculture Faisalabad, Pakistan; 3Department of Biochemistry, Faculty of Sciences, University of Agriculture Faisalabad, Pakistan. *Corresponding author’s e-mail: [email protected] The aim of current investigation was to assess total phenolics (TPC), total flavonoids (TFC) and punicalagin content (PC) of pomegranate peel extracts (PPEs) for its utilization as functional ingredient in food processing industry. Antioxidant rich fractions were extracted from Punica granatum L. (pomegranate) peel using methanol, ethanol and ethyl acetate. Furthermore, the extracts were characterized to assess their antioxidant potential using in vitro DPPH assay model. Methanolic extracts inhibited 78.23% free radicals; however ethyl acetate extracts showed least antioxidant activity. Maximum phenolic and flavonoid contents were extracted in methanolic extracts that were documented as 289.40 ± 12.75 mg/g GAE (Gallic acid equivalents) and 58.63±3.41 mg/g RE (Rutin equivalents), respectively, whereas punicalagin (110.00 ± 5.10 mg/g) was the major ellagitannin detected and quantified. Significant correlation (r = 0.981, 0.958; N = 3) was observed between total phenolics, total flavonoids and antioxidant activity of respective extracts.
    [Show full text]
  • Antioxidant Activity of Pomegranate Juice and Its Relationship with Phenolic Composition and Processing
    J. Agric. Food Chem. 2000, 48, 4581−4589 4581 Antioxidant Activity of Pomegranate Juice and Its Relationship with Phenolic Composition and Processing Marı´a I. Gil,† Francisco A. Toma´s-Barbera´n,† Betty Hess-Pierce,‡ Deirdre M. Holcroft,§ and Adel A. Kader*,‡ Department of Pomology, University of California, Davis, California 95616, Department of Food Science and Technology, CEBAS (CSIC), P.O. Box 4195, Murcia 30080, Spain, and Department of Horticultural Science, Private Bag X1, Matieland 7602, South Africa The antioxidant activity of pomegranate juices was evaluated by four different methods (ABTS, DPPH, DMPD, and FRAP) and compared to those of red wine and a green tea infusion. Commercial pomegranate juices showed an antioxidant activity (18-20 TEAC) three times higher than those of red wine and green tea (6-8 TEAC). The activity was higher in commercial juices extracted from whole pomegranates than in experimental juices obtained from the arils only (12-14 TEAC). HPLC- DAD and HPLC-MS analyses of the juices revealed that commercial juices contained the pomegranate tannin punicalagin (1500-1900 mg/L) while only traces of this compound were detected in the experimental juice obtained from arils in the laboratory. This shows that pomegranate industrial processing extracts some of the hydrolyzable tannins present in the fruit rind. This could account for the higher antioxidant activity of commercial juices compared to the experimental ones. In addition, anthocyanins, ellagic acid derivatives, and hydrolyzable tannins were detected and quantified in the pomegranate juices. Keywords: Pomegranate; Punica granatum; Punicaceae; juice; phenolics; anthocyanins; ellagic acid; punicalagin; tannins; antioxidant activity; ABTS; DPPH; DMPD; FRAP INTRODUCTION 1986b), leaf (Tanaka et al., 1985; Nawwar et al., 1994b), and the fruit husk (Mayer et al., 1977) are very rich in Epidemiological studies show that consumption of ellagitannins and gallotannins.
    [Show full text]
  • Investigation, Formulation and Evaluation of Antidiabetic Tablet of Punicagranatum Peel
    International Journal of Pharmacy and Biological Sciences ISSN: 2321-3272 (Print), ISSN: 2230-7605 (Online) IJPBS | Volume 8 | Issue 2 | APR-JUN | 2018 | 813-822 Research Article | Pharmaceutical Sciences | Open Access | MCI Approved| |UGC Approved Journal | INVESTIGATION, FORMULATION AND EVALUATION OF ANTIDIABETIC TABLET OF PUNICAGRANATUM PEEL Ghodke Amol D1*, Jain Shirish P, Ambore Sandeep M, Shelke Satish P and Bochare Umesh J Rajarshi Shahu College of Pharmacy, Buldana, Maharashtra, India *Corresponding Author Email: [email protected] ABSTRACT The present study was aimed to formulate & evaluate the antidiabetic tablet of Punicagranatum peels waste. Hyperglycemia is the most common metabolic endocrine disorder. It is the chronic condition in which blood glucose level is elevated than normal due to the improper insulin production in body or due to insulin resistance, high blood glucose level and low blood glucose level leads to diabetic condition. Allopathic treatment for diabetes mellitus is too costly so focus on herbal medicines is necessary. Pomegranate peels or rind are considered as an waste material these peels consists of numerous important active chemical constituents such as flavonoids, vitamins and minerals. The main principle active chemical constituents including punicalagin, punicalin, β-sitosterol and valoneic acid dilactone (VAD) from pomegranate peels powder shows potent antidiabetic activity Punicagranatum peels extract have stability problem than other dosage form by converting it into tablet dosage form. We enhance its acceptability, elegance and patient compliance. Manufacturing of tablets was done by using wet granulation method on lab level tablet press (CEMACH) by wet granulation method. Evaluations tests performed on tablets such as Hardness, Weight variation, friability, disintegration test etc KEY WORDS punicagranatum, antidiabetic, valoneic acid dilactone (VAD), herbal medicine 1.INTRODUCTION: 1.2 Common Name: [17-20] Diabetes mellitus is a metabolic disorder identified as i.
    [Show full text]